We are live on ! Find out more
PCM

Puissance Capital Management Portfolio holdings

AUM $17.3M
1-Year Est. Return 149.36%
This Fund
S&P 500
This Quarter Est. Return
-4.68%
1 Year Est. Return
+149.36%
3 Year Est. Return
+115.5%
5 Year Est. Return
10 Year Est. Return
AUM
$102M
AUM Growth
-$20.8M
Cap. Flow
+$546K
Cap. Flow %
0.53%
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
SCYX icon
SCYNEXIS
SCYX
+$546K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 25.52%
2 Healthcare 10.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRAY
1
DELISTED
ViewRay, Inc.
VRAY
$60.3M 59%
6,842,975
CHRN
2
ChronoScale Holdings
CHRN
$2.69B
$26.1M 25.52%
91,266
KDMN
3
DELISTED
Kadmon Holdings, Inc.
KDMN
$6.15M 6.02%
3,020,596
BLPH
4
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$4.97M 4.87%
553,250
TCON
5
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$3.13M 3.06%
23,009
CRVS icon
6
Corvus Pharmaceuticals
CRVS
$1.1B
$1.06M 1.04%
284,869
SCYX icon
7
SCYNEXIS
SCYX
$37.4M
$496K 0.49%
+4,735
New +$546K

Similar funds

Puissance Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Puissance Capital Management held 7 positions worth $102M, down 17% from $123M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Puissance Capital Management's Q2 2019 filing shows 1 new position. Its largest new stake was SCYNEXIS: 4,735 shares worth $496K.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 42% a quarter earlier, followed by Healthcare.

  • Puissance Capital Management's largest Q2 2019 buy was SCYNEXIS: 4,735 shares worth $496K.
  • Puissance Capital Management's ten largest holdings make up 100% of its $102M portfolio in Q2 2019.
  • Puissance Capital Management opened 1 new position and closed 0 in Q2 2019.
  • Puissance Capital Management's portfolio value fell 17% quarter-over-quarter to $102M.

Based on Puissance Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.